松弛型纤连蛋白:子宫内膜异位病灶成像的潜在新靶点
本研究旨在寻找可成像活动性子宫内膜异位病灶的靶点,采用临床前放射性示踪剂[111In]In-FnBPA5(特异性结合松弛型纤连蛋白)在小鼠中进行生物分布与SPECT/CT研究,并对小鼠子宫组织及患者来源子宫内膜异位组织进行免疫组化染色。结果显示小鼠肌层对示踪剂的摄取随动情周期变化,雌激素依赖期摄取更高,提示雌激素水平高时松弛型纤连蛋白丰度增加;患者样本免疫组化显示子宫内膜异位间质附近纤连蛋白优先松弛化。作者认为松弛型纤连蛋白可能是开发靶向子宫内膜异位病灶诊断性放射性示踪剂的潜在靶点,[111In]In-FnBPA5是处于临床前开发的匹配靶向分子。
要点
- 小鼠肌层对[111In]In-FnBPA5的摄取随动情周期变化,雌激素依赖期摄取更高。
- 患者子宫内膜异位组织免疫组化显示异位间质附近纤连蛋白优先松弛化。
- 松弛型纤连蛋白可能是成像活动性子宫内膜异位病灶的潜在靶点。
核心结论
- 以高雌激素水平为特征的动情周期阶段使小鼠肌层中松弛型纤连蛋白丰度更高。
- 结合人体子宫内膜异位组织首次概念验证研究,松弛型纤连蛋白可能是开发靶向子宫内膜异位病灶诊断性放射性示踪剂的潜在靶点。
- [111In]In-FnBPA5是处于临床前开发的匹配靶向分子。
研究设计与样本
- 采用临床前放射性示踪剂[111In]In-FnBPA5进行小鼠生物分布与SPECT/CT研究。
- 对小鼠子宫组织及患者来源子宫内膜异位组织进行免疫组化染色。
主要发现
- 生物分布与SPECT/CT研究显示小鼠肌层对[111In]In-FnBPA5的摄取随动情周期变化,雌激素依赖期摄取更高。
- 提示雌激素水平高时松弛型纤连蛋白丰度增加。
- 患者样本免疫组化分析显示子宫内膜异位间质附近纤连蛋白优先松弛化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endometriosis is characterized by the ectopic occurrence of endometrial tissue. Though considered benign, endometriotic lesions possess tumor-like properties such as tissue invasion and remodeling of the extracellular matrix. One major clinical hurdle concerning endometriosis is its diagnosis. The diagnostic modalities ultrasound and MRI are often unable to detect all lesions, and a clear correlation between imaging and clinical symptoms is still controversial. Therefore, it was our aim to identify a potential target to image active endometriotic lesions. RESULTS: For our studies, we employed the preclinical radiotracer [111In]In-FnBPA5, which specifically binds to relaxed fibronectin-an extracellular matrix protein with key functions in homeostasis that has been implicated in the pathogenesis of diseases such as cancer and fibrosis. We employed this tracer in biodistribution as well as SPECT/CT studies in mice and conducted immunohistochemical stainings on mouse uterine tissue as well as on patient-derived endometriosis tissue. In biodistribution and SPECT/CT studies using the radiotracer [111In]In-FnBPA5, we found that radiotracer uptake in the myometrium varies with the estrous cycle of the mouse, leading to higher uptake of [111In]In-FnBPA5 during estrogen-dependent phases, which indicates an increased abundance of relaxed fibronectin when estrogen levels are high. Finally, immunohistochemical analysis of patient samples demonstrated that there is preferential relaxation of fibronectin in the proximity of the endometriotic stroma. CONCLUSION: Estrous cycle stages characterized by high estrogen levels result in a higher abundance of relaxed fibronectin in the murine myometrium. This finding together with a first proof-of-concept study employing human endometriosis tissues suggests that relaxed fibronectin could be a potential target for the development of a diagnostic radiotracer targeting endometriotic lesions. With [111In]In-FnBPA5, the matching targeting molecule is in preclinical development.
引用
- Trachsel B, Imobersteg S, Valpreda G, et al. Relaxed fibronectin: a potential novel target for imaging endometriotic lesions. EJNMMI Res. 2024. PMID: 38340184. doi:10.1186/s13550-024-01070-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。